Cargando…
Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
PURPOSE: We analyzed the prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors (PDE5Is) in the urology department as well as in other departments of the general hospital. METHODS: We investigated the frequency of prescription of alpha-blockers and PDE5Is from 3 general hospitals from Ja...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Continence Society
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256307/ https://www.ncbi.nlm.nih.gov/pubmed/22259736 http://dx.doi.org/10.5213/inj.2011.15.4.216 |
_version_ | 1782221066085597184 |
---|---|
author | Kang, Dong Hyuk Lee, Joo Yong Chung, Jae Hoon Cho, Hee Ju Cho, Jeong Man Moon, Hong Sang Kim, Yong Tae Yoo, Tag Keun Choi, Hong Yong Park, Hae Young Lee, Seung Wook |
author_facet | Kang, Dong Hyuk Lee, Joo Yong Chung, Jae Hoon Cho, Hee Ju Cho, Jeong Man Moon, Hong Sang Kim, Yong Tae Yoo, Tag Keun Choi, Hong Yong Park, Hae Young Lee, Seung Wook |
author_sort | Kang, Dong Hyuk |
collection | PubMed |
description | PURPOSE: We analyzed the prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors (PDE5Is) in the urology department as well as in other departments of the general hospital. METHODS: We investigated the frequency of prescription of alpha-blockers and PDE5Is from 3 general hospitals from January 1, 2007 to December 31, 2009. For alpha-blockers, data were collected from patients to whom alpha-blockers were prescribed from among patients recorded as having benign prostatic hyperplasia according to the 5th Korean Standard Classification of Diseases. For PDE5Is, data were collected from patients to whom PDE5Is were prescribed by the urology department and by other departments. Alpha-blockers were classified into tamsulosin, alfuzosin, doxazosin, and terazosin, whereas PDE5Is were classified into sildenafil, tadalafil, vardenafil, udenafil, and mirodenafil. RESULTS: Alpha-blockers were prescribed to 11,436 patients in total over 3 years, and the total frequency of prescriptions was 68,565. Among other departments, the nephrology department had the highest frequency of prescription of 3,225 (4.7%), followed by the cardiology (3,101, 4.5%), neurology (2,576, 3.8%), endocrinology (2,400, 3.5%), pulmonology (1,102, 1.6%), and family medicine (915, 1.3%) departments in order. PDE5Is were prescribed to 2,854 patients in total over 3 years, and the total frequency of prescriptions was 10,558. The prescription frequency from the urology department was 4,900 (46.4%). Among other departments, the endocrinology department showed the highest prescription frequency of 3,488 (33.0%), followed by the neurology (542, 5.1%), cardiology (467, 4.4%), and family medicine (407, 3.9%) departments in order. CONCLUSIONS: A high percentage of prescriptions of alpha-blockers and PDE5Is were from other departments. For more specialized medical care by urologists is required in the treatment of lower urinary tract symptoms and erectile dysfunction. |
format | Online Article Text |
id | pubmed-3256307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Korean Continence Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-32563072012-01-18 Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments Kang, Dong Hyuk Lee, Joo Yong Chung, Jae Hoon Cho, Hee Ju Cho, Jeong Man Moon, Hong Sang Kim, Yong Tae Yoo, Tag Keun Choi, Hong Yong Park, Hae Young Lee, Seung Wook Int Neurourol J Original Article PURPOSE: We analyzed the prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors (PDE5Is) in the urology department as well as in other departments of the general hospital. METHODS: We investigated the frequency of prescription of alpha-blockers and PDE5Is from 3 general hospitals from January 1, 2007 to December 31, 2009. For alpha-blockers, data were collected from patients to whom alpha-blockers were prescribed from among patients recorded as having benign prostatic hyperplasia according to the 5th Korean Standard Classification of Diseases. For PDE5Is, data were collected from patients to whom PDE5Is were prescribed by the urology department and by other departments. Alpha-blockers were classified into tamsulosin, alfuzosin, doxazosin, and terazosin, whereas PDE5Is were classified into sildenafil, tadalafil, vardenafil, udenafil, and mirodenafil. RESULTS: Alpha-blockers were prescribed to 11,436 patients in total over 3 years, and the total frequency of prescriptions was 68,565. Among other departments, the nephrology department had the highest frequency of prescription of 3,225 (4.7%), followed by the cardiology (3,101, 4.5%), neurology (2,576, 3.8%), endocrinology (2,400, 3.5%), pulmonology (1,102, 1.6%), and family medicine (915, 1.3%) departments in order. PDE5Is were prescribed to 2,854 patients in total over 3 years, and the total frequency of prescriptions was 10,558. The prescription frequency from the urology department was 4,900 (46.4%). Among other departments, the endocrinology department showed the highest prescription frequency of 3,488 (33.0%), followed by the neurology (542, 5.1%), cardiology (467, 4.4%), and family medicine (407, 3.9%) departments in order. CONCLUSIONS: A high percentage of prescriptions of alpha-blockers and PDE5Is were from other departments. For more specialized medical care by urologists is required in the treatment of lower urinary tract symptoms and erectile dysfunction. Korean Continence Society 2011-12 2011-12-31 /pmc/articles/PMC3256307/ /pubmed/22259736 http://dx.doi.org/10.5213/inj.2011.15.4.216 Text en Copyright © 2011 Korean Continence Society http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (http://creativecommons.org/licenses/by-nc/3.0) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kang, Dong Hyuk Lee, Joo Yong Chung, Jae Hoon Cho, Hee Ju Cho, Jeong Man Moon, Hong Sang Kim, Yong Tae Yoo, Tag Keun Choi, Hong Yong Park, Hae Young Lee, Seung Wook Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments |
title | Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments |
title_full | Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments |
title_fullStr | Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments |
title_full_unstemmed | Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments |
title_short | Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments |
title_sort | analysis of prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors from the urology department and other departments |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256307/ https://www.ncbi.nlm.nih.gov/pubmed/22259736 http://dx.doi.org/10.5213/inj.2011.15.4.216 |
work_keys_str_mv | AT kangdonghyuk analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments AT leejooyong analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments AT chungjaehoon analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments AT choheeju analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments AT chojeongman analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments AT moonhongsang analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments AT kimyongtae analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments AT yootagkeun analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments AT choihongyong analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments AT parkhaeyoung analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments AT leeseungwook analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments |